-
Dosimetry of Beryllium in an Animal Model by Accelerator Mass Spectrometry (AMS)Marina Chiarappa-Zucca R.C. Finkel J.E. McAninch R.E. MartinelliK.W. Turteltaub
Lawrence Livermore National Laboratory University of California
-
Our aim is to develop a method to quantify attomole (10-18) amounts of Be in biological samples
This method should enable the identification of molecular targets of Be at very low doses and provide detailed characterization of Be dosimetry
Demonstration of this capability will facilitate research collaborations on the cellular and molecular mechanisms of CBD
-
Outline
IntroductionWhat is accelerator mass spectrometry (AMS)?
Experimental Approach Sample preparation steps for extracting Be for AMS AMS measurement of Be standards Data from experiments showing Be distribution in mouse tissues
Conclusions
-
What is AMS?
-
AMS provides high sensitivity measurements of long-lived (10 < t1/2 > 107 yrs) radioisotopesAMS counts nuclei directly rather then measuring radioactive decay This results in 3-9 orders of magnitude more sensitivity relative to scintillation countingAllows analysis of attomole quantities in small samples (g-mg) with low activity levels (nCi-fCi) LLNL has 15 years of experience with AMS and has pioneered the bioscience applications
-
Accelerators at Lawrence Livermore National Laboratory64 samples (plus standards and blanks) measured as a set>100 unknowns can be quantified in 24 hr of accelerator time14C BioAMSTandem; multiple isotopes including 10Be
-
AMS can be used to measure 10BeRoutine sensitivity is ~0.02 fgExperiments require fCi total activities10Be has a long half life (1.6 My) and therefore can be measured in samples from months to years10Be in low dose experiments can typically be handled as non-radioactive and non-hazardous
10Be has significant advantages compared to other Be isotopes
-
Sample Preparation Steps
-
There are multiple steps for extracting Be from samples for AMS measurement
-
AMS Measurements of Standards
-
AMS measurement of standards is linear in the range of interest with good precision Each data point represents the mean SD of three independently prepared standards Instrument precision is 1-3%
-
Proof-of-Concept Experiment
-
Proof of concept experiments show Be distribution in mouse tissues30 g male ICR miceIntraperitoneal injection of 0.05, 0.5, and 5.0 g Be (~2-200 g/kg body weight) Three mice used for each dose 24 hr exposureLiver, spleen, kidneys, lung, blood, and femurs prepared for AMS analysis
-
Be measured in tissues is dose-dependent within dose range studied
*** Spleen and blood data extrapolated to determine dose limits with current MDL
~ 200 pg (.007 g/kg bw) * ~ 0.01 g (0.3 g/kg bw) **These doses are below environmental Be exposures (e.g. for humans 0.9 0.5 g/kg bw)
Chart2
3.77170546847.89765865221.73669062170.04109199880.19340648591.0477366845
2.14569816247.20763742892.31701663850.07941291280.12377329820.6756918431
10.20822284011.63011791591.13326149690.04391236630.12824886081.1235906625
20.704418004779.448638924346.34682765532.44942345472.68703490244.9599909109
4.112684842764.029046314914.89823984880.618891377231.7987111452.7446725152
6.0022592893121.289148120519.88711496581.71246215432.49922261834.5067601522
62.0671950111145.813078192953.200645243925.557979398323.0775803248
155.25094355341387.099290524252.653355661546.578035996359.5358522573
159.39358618795515.905083781463.260774886841.8791965453
Femur
Spleen
Liver
Blood
Lung
Kidney
Sheet1
9Be/tissue
microgrammicrog/g
DoseLivererror (ng)Spleenerror (ng)Femurerror (ng)Blooderror (ng)Lungerror (ng)Kidneyerror (ng)
0.051.7370.0187.8980.1633.7720.0720.0410.0040.1930.0101.0480.024
0.052.3170.0267.2080.1122.1460.0700.0790.0030.1240.0080.6760.012
0.051.1330.0131.6300.04110.2081.5160.0440.0050.1280.0101.1240.034
0.546.3470.41979.4492.35520.7040.1662.4490.0292.6870.0884.9600.053
0.514.8980.49264.0291.5454.1130.0480.6190.01331.7990.3392.7450.031
0.519.8870.223121.2891.9876.0020.1541.7120.0242.4990.0354.5070.048
51145.81311.20162.0671.1313.2010.03825.5580.17723.0781.022
51387.09915.293155.2515.7972.6530.03146.5780.45559.5361.659
5159.39411.58415.9050.18063.2610.43741.8791.585
microgram
DoseLiverlogSpleenFemurBloodbloodLungKidney
0.051.7370.2407.8980.8973.7720.041-1.3860.1931.048
0.052.3170.3657.2080.8582.1460.079-1.1000.1240.676
0.051.1330.0541.6300.21210.2080.044-1.3570.1281.124
0.546.3471.66679.4491.90020.7042.4490.3892.6874.960
0.514.8981.17364.0291.8064.1130.619-0.20831.7992.745
0.519.8871.299121.2892.0846.0021.7120.2342.4994.507
51145.8133.05962.0673.2010.50525.55823.078
51387.0993.142155.2512.6530.42446.57859.536
5159.39415.9051.20263.26141.879
Sheet1
Femur
Spleen
Liver
Blood
Lung
Kidney
Sheet2
Sheet3
-
ConclusionsAMS provides high sensitivity 10Be measurements in biological samplesOur future direction is to study mechanisms of Be diseaseExplore molecular dosimetryIdentify molecular (e.g. protein) targets that are responsible or involved in CBDEvaluate the correlation between these endpoints and susceptibility to CBD We are ready now to collaborate with other researchers that have specific applications for this capability
-
Funding
Office of Biological and Environmental ResearchU.S. Department of Energy
Our group has been doing research focused on understanding the effects of very low levels of toxicants and drugs on animal and human health. We study the molecular mechanisms involved and how they might relate to disease. One of the tools we have been using for the past 15 years is AMS. We thought our contribution to understanding CBD was to develop an AMS method that could measure low levels of Be-fate-distribution In animals, cells, humans
Sensitivity depends on isotope measured
Method developed for tritium and dual label tracing of 3H and 14C
Small machine funded in part by DOE and other part by NIH10,000 sq ft buildingBriefly:Nitric acid, hydrofluoric acid,with hydrogen peroxide and ammonium persulfateSample taken to dryness and re-suspended in waterBe is precipitated with NaOH and centrifugedAdded to the disposable crucibleOxidized to BeO at 800 degrees centrigradeMixed with Niobium powder and packedDefine MDL: mean of replicate control tissue samples plus 3 SDStandards counted by LSC and compared to NIST standardsHigh precision; Standards are accurate and the dynamic range is 3 orders of magnitude for our specific application We measured nanogram quantities of Be in all the tissues Graph shows Be content (y axis) and Dose administered on the x axisOne group had a higher Be content then the other. Femurs, Spleen, and Liver (shown in yellow) Be content in Blood, lung, and kidney (shown in blue) had about 10X lower BeBe measured in tissues is dose-dependent between 0.05 and 5 g range givenExtrapolationEnvironmental exposures-for comparison purposes More experiments underway to test thisStudy the fate and distribution of Be in animals We can also trace Be and any associated proteins inside or outside a cellCorrelation and endpoints: such as the relationship to genetic variants thought to be involved with CBD and animal models as they developThank you and I will be happy to take any questions